CDC Update on Bundibugyo Ebola Outbreak Response in DRC and Uganda

The Centers for Disease Control and Prevention (CDC) is currently managing a fluid response to an emerging outbreak of the Bundibugyo virus, a species of Ebola, identified in the Ituri Province region of the Democratic Republic of Congo (DRC). Initially, standard gene expert testing failed to detect this specific species, leading to a high index of suspicion that prompted further testing and genomic sequencing to confirm the diagnosis.

Responding to a Growing Outbreak

The CDC is working in tandem with the Ministry of Health and international partners to contain the virus. Efforts on the ground include the deployment of 20 trained disease detectives to the outbreak zone and the training of 50 local community healthcare workers to improve early reporting. In Uganda, an additional 23 CDC-trained field epidemiologists are actively supporting response operations.

To bolster these efforts, the CDC is preparing to send seven headquarters-based subject matter experts in viral hemorrhagic fever to provide technical support in both the DRC and Uganda. These teams are focusing on infection prevention, contact tracing, and addressing logistical gaps in the region.

Did You Know? The Bundibugyo virus was identified after initial routine tests failed to detect it, highlighting the necessity of advanced genomic sequencing in managing outbreaks of less common viral species.

Risk Assessment and Travel Protocols

While the situation in the DRC continues to evolve, the CDC maintains that the risk to the United States remains low. This assessment is based on the fact that Ebola is transmitted only through direct contact with body fluids, and the U.S. Maintains robust healthcare preparedness and monitoring systems.

Africa CDC Special Emergency Briefing: Ebola (Bundibugyo) Outbreak Update || May 23, 2026

The CDC has implemented a layered approach to travel safety, which includes exit screening in affected countries and entry screening for travelers arriving in the U.S. Through Dulles International Airport. These measures involve temperature checks, questionnaires, and evaluations to determine if travelers require further monitoring or intervention based on their recent history in the affected regions.

Expert Insight: The decision to centralize entry screening at specific ports of entry like Dulles reflects a strategic effort to manage resources effectively while maintaining a high standard of public health surveillance. The reliance on established partnerships in the DRC and Uganda is critical, as these long-standing relationships facilitate the rapid deployment of resources and the continuity of contact tracing efforts during a crisis.

Looking Ahead

As the outbreak continues to expand, the CDC may adjust its guidance and travel measures to meet evolving demands. The agency is also working with interagency partners, including BARDA and ASPR, to evaluate the current landscape of medical countermeasures. Because no FDA-approved treatments for the Bundibugyo virus currently exist, the focus remains on identifying the most appropriate therapies and ensuring they can be delivered safely and effectively if needed.

Frequently Asked Questions

Can I contract Ebola through casual contact at an airport?
No. The CDC emphasizes that Ebola is not spread through passing someone in an airport, sitting near them briefly, or other forms of casual contact. Transmission requires direct contact with body fluids.

Are there FDA-approved treatments for the Bundibugyo virus?
Currently, there are no FDA-approved medical countermeasures for this specific strain. The U.S. Government is actively evaluating the landscape of available products to determine the best path forward for potential treatment.

Why is the CDC using Dulles International Airport for screening?
The CDC determined that the volume of inbound travel from the affected regions could be managed through this specific port of entry. The agency continues to evaluate this process and may adjust protocols if demand changes.

How do you think global health organizations can best balance the need for rapid emergency response with the long-term goal of building local medical infrastructure?